- Report
- February 2022
- 167 Pages
Global
From €3928EUR$4,450USD£3,392GBP
- Report
- January 2022
- 148 Pages
Global
From €3928EUR$4,450USD£3,392GBP
- Report
- September 2021
- 181 Pages
Global
From €3928EUR$4,450USD£3,392GBP
- Report
- September 2022
- 162 Pages
Global
From €3178EUR$3,600USD£2,744GBP
- Report
- January 2021
- 245 Pages
Global
From €3178EUR$3,600USD£2,744GBP
- Report
- January 2025
- 94 Pages
From €3045EUR$3,450USD£2,630GBP
- Report
- June 2024
- 120 Pages
Global
From €4409EUR$4,995USD£3,808GBP
- Report
- July 2024
- 97 Pages
Middle East, Africa
From €3045EUR$3,450USD£2,630GBP
- Report
- August 2023
- 188 Pages
Global
From €3928EUR$4,450USD£3,392GBP
- Report
- March 2024
- 136 Pages
Global
From €3751EUR$4,250USD£3,240GBP
- Report
- January 2022
- 132 Pages
Global
From €3928EUR$4,450USD£3,392GBP
- Report
- October 2023
- 180 Pages
Global
From €1103EUR$1,250USD£953GBP
€2207EUR$2,500USD£1,906GBP
- Report
- February 2026
- 193 Pages
Canada
From €4281EUR$4,850USD£3,697GBP
- Report
- February 2026
- 202 Pages
China
From €4281EUR$4,850USD£3,697GBP
- Report
- January 2026
- 150 Pages
Japan
From €4281EUR$4,850USD£3,697GBP
- Report
- April 2023
- 111 Pages
Asia Pacific
From €3045EUR$3,450USD£2,630GBP
- Report
- July 2024
- 153 Pages
Global
From €3189EUR$3,613USD£2,754GBP
€3751EUR$4,250USD£3,240GBP
- Report
- October 2025
- 108 Pages
Australia
From €2647EUR$2,999USD£2,286GBP
- Report
- June 2025
- 109 Pages
Colombia
From €3177EUR$3,599USD£2,743GBP
- Report
- May 2025
- 90 Pages
Global
From €3500EUR$4,248USD£3,128GBP

The Eye Disease market within the Optical industry is a rapidly growing sector, with a focus on providing treatments and solutions for a variety of eye conditions. This includes the diagnosis and management of conditions such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy. Companies in this market are developing innovative technologies to improve the accuracy and speed of diagnosis, as well as treatments to improve patient outcomes.
The Eye Disease market is also focused on providing solutions to improve patient access to care, such as telemedicine and remote monitoring. This is helping to reduce the burden on healthcare systems and improve patient outcomes.
Companies in the Eye Disease market include Alcon, Bausch + Lomb, Carl Zeiss Meditec, Essilor, Hoya, Johnson & Johnson Vision, Novartis, and Topcon. Show Less Read more